NCT07521436

Brief Summary

The present research project aims to assess, through a survey, awareness of general and sex/gender-specific cardiovascular risk factors, as well as the perception of the risk of developing further cardiovascular diseases, among patients in secondary prevention.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Apr 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Apr 2026Jan 2027

First Submitted

Initial submission to the registry

April 3, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 9, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

April 10, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2027

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

April 3, 2026

Last Update Submit

April 28, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Awareness of cardiovascular risk factors

    Mean cardiovascular risk factor knowledge score, defined as the total number of correctly identified cardiovascular risk factors.

    At enrollment

  • Self-reported risk perception of CVD

    Defined as percentage of categorical variables (low, medium, high)

    At enrollment

  • Self-reported comparative risk perception

    Individual subjective evaluation of their own risk relative to a reference group (individuals of the same age and of the same or opposite biological sex), measured as a categorical variable (lower/equal/higher/unknown) (Self-reported comparative risk perception).

    At enrollment

Secondary Outcomes (3)

  • Differences among females and males in self-assessed risk perception

    At enrollments

  • Differences among females and males in self-reported comparative risk perception

    At enrollment

  • Comparisons between responders in primary and secondary prevention

    At enrollment

Interventions

There is not an intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study involves the recruitment of adult patients attending the cardiology outpatient clinics of the participating centers who meet the inclusion criteria. Participation will be voluntary and contingent upon the signing of informed consent. Patients will complete the questionnaire in a self-administered format, either on paper or digitally via their own device (smartphone or tablet), according to their preference.

You may qualify if:

  • Male or female participants aged ≥ 18 years at the time of signing informed consent.
  • Individuals with atherosclerotic cardiovascular disease (ASCVD), defined as at least one of the following:
  • Ischemic heart disease (e.g., documented myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting, or ≥50% coronary stenosis in at least two coronary territories);
  • Cerebrovascular disease (e.g., documented ischemic stroke; transient ischemic attack, primary intracerebral hemorrhage, and subarachnoid hemorrhage are not qualifying conditions; carotid stenting or endarterectomy);
  • Peripheral arterial disease (e.g., peripheral arterial intervention, stent placement, surgical revascularization, lower limb amputation due to obstructive disease, or intermittent claudication with ABI \<0.90 in the past 12 months);
  • Atherosclerotic aortic disease (e.g., abdominal or descending thoracic aortic aneurysm).
  • Signed informed consent.

You may not qualify if:

  • Inability or difficulty in completing the questionnaires in Italian and/or functional illiteracy.
  • History of or current severe psychiatric disorder that could compromise the reliability of questionnaire responses.
  • Refusal or withdrawal of informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituti Clinici Scientifici IRCCS Maugeri

Milan, Italy

RECRUITING

MeSH Terms

Conditions

Cardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2026

First Posted

April 9, 2026

Study Start

April 10, 2026

Primary Completion (Estimated)

January 10, 2027

Study Completion (Estimated)

January 10, 2027

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations